Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase

Khalid Hussain Wali Sait1, Qamre Alam2, Nisrin Anfinan3

  • 1Department of Obstetrics and Gynecology, Gynecology Oncology Unite, Faculty of Medicine, King Abdulaziz University, Jeddah, SaudiArabia.

Bioinformation
|July 10, 2019
PubMed

Insights

This study identifies potential new drugs targeting the Epidermal Growth Factor Receptor (EGFR) to overcome docetaxel resistance in ovarian cancer. These compounds show promise for enhancing chemotherapy effectiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epidermal Growth Factor Receptor (EGFR) is often deregulated in ovarian cancer, leading to STAT3 activation, anti-apoptotic effects, and docetaxel resistance.
  • Targeting EGFR in combination with docetaxel is a key strategy to improve treatment sensitivity in ovarian cancer.

Purpose of the Study:

  • To investigate the structural and functional properties of IBS Database compounds as potential EGFR tyrosine kinase inhibitors.
  • To evaluate the pharmacokinetic profile of these compounds using ADMET analysis.

Main Methods:

  • Molecular simulation studies were employed to assess the binding affinity and interactions of compounds with the EGFR active site.
  • In silico methods were used for natural activity spectrum prediction and ADMET pharmacokinetic profiling.

Main Results:

  • STOCK1N-98911, STOCK1N-98869, and STOCK1N-98896 demonstrated significant binding energy by interacting with key residues in the EGFR active site.
  • Natural activity spectrum prediction indicated potential anticancer properties through significant interaction with EGFR tyrosine kinase.

Conclusions:

  • The identified compounds show potential as EGFR inhibitors, offering a promising avenue for overcoming docetaxel resistance in ovarian cancer.
  • Further clinical, toxicological, and pharmacokinetic studies are warranted to validate these findings.

Related Concept Videos

Molecular Structure and Acidity02:34

Molecular Structure and Acidity

An acid can be deprotonated to form a conjugate base or an anion. If the produced anion is more stable, then the acid is stronger. On the contrary, if the anion is unstable, then the acid is weaker. Hence, to determine the acidity of the compound, the stability of its conjugate base is studied using various factors.
The size effect explains the change in atomic size on acidity. When comparing the acids formed from elements that belong to the same column in the periodic table, their atomic sizes...
20.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Acid Strength and Molecular Structure03:05

Acid Strength and Molecular Structure

Binary Acids and Bases
In the absence of any leveling effect, the acid strength of binary compounds of hydrogen with nonmetals (A) increases as the H-A bond strength decreases down a group in the periodic table. For group 17, the order of increasing acidity is HF < HCl < HBr < HI. Likewise, for group 16, the order of increasing acid strength is H2O < H2S < H2Se < H2Te. Across a row in the periodic table, the acid strength of binary hydrogen compounds increases with increasing...
32.9K
Lewis Structures of Molecular Compounds and Polyatomic Ions02:54

Lewis Structures of Molecular Compounds and Polyatomic Ions

To draw Lewis structures for complicated molecules and molecular ions, it is helpful to follow a step-by-step procedure as outlined:
44.9K
Structure of Benzene: Molecular Orbital Model01:18

Structure of Benzene: Molecular Orbital Model

According to the molecular orbital (MO) model, benzene has a planar structure with a regular hexagon of six sp2 hybridized carbons. As shown in Figure 1, each carbon is bonded to three other atoms with C–C–C and H–C–C bond angles of 120°. The C–H bond length is 109 pm, and the C–C bond length is 139 pm which is midway between the single bond length of sp3 hybridized carbons (154 pm) and sp2 hybridized carbons (133 pm).
12.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
464